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Abstract
We present a case of distal renal tubular acidosis and acute renal insufficiency in a patient with
Waldenström’s macroglobulinemia. Distal renal tubular acidosis has been described in hypergam-
maglobulinemia, but not in patients with Waldenström’s macroglobulinemia. To our knowledge, this
is the first report to describe a possible association between distal renal tubular acidosis and
Waldenström’s macroglobulinemia. Our case also emphasizes the importance of prompt recognition
of distal renal tubular acidosis in patients with Waldenström’s macroglobulinemia because of its
metabolic disturbances and potentially life threatening complications.
Introduction
Waldenström’s macroglobulinemia is a lymphoprolifera-
tive disease characterized by the excessive production of
IgM monoclonal protein. It is estimated that each year
1400 new cases occur in the United States [1]. Chronic
renal insufficiency is unusual in Waldenström’s macro-
globulinemia and is mostly caused by IgM deposits in the
glomerular capillaries, interstitial infiltration of lymphoid
cells, or amyloidosis [2-5]. In addition, distal renal tubular
acidosis (RTA) has been described in hypergammaglobu-
linemia [6,7], but not in patients with Waldenström’s
macroglobulinemia. We present a case of long-standing
distal renal tubular acidosis (RTA) in a patient with
Waldenström’s macroglobulinemia who came to our
hospital because of acute renal dysfunction. In this case,
Waldenström’s macroglobulinemia may have been a
major contributor to her long-standing distal renal tubular
acidosis and possibly to her acute renal dysfunction.
Case presentation
An 84-year old Caucasian female was admitted to our
hospital with muscle cramps and increasing lethargy
during the past few days. Her medical history was signi-
ficant for Waldenström’s macroglobulinemia, hyperten-
sion, paroxysmal atrial fibrillation, hyperlipidemia, and
chronic kidney disease. Waldenström’s macroglobu-
linemia was previously diagnosed by serum-, urine- and
immuno-electrophoresis revealing monoclonal produc-
tion of IgM protein and flow cytometry demonstrating
kappa restricted monoclonal B-cells with typical immu-
nophenotype. A review of medical records also revealed
that the patient had a long-standing history of distal
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high urinary pH, suggestive of distal RTA. She has then
progressively developed nephrocalcinosis and renal
dysfunction.
Prior to admission, the patient was not started on any new
medications. On physical examination, the patient was
alert and oriented with mild pedal edema on both legs.
There was no musculoskeletal pain or rash. Examination
of the cardiorespiratory system and abdomen was
unremarkable. Admission laboratory results are demon-
strated (Table 1). The patient presented with acute renal
dysfunction and a mixed anion gap and non-anion gap
metabolic acidosis. There was also an elevated total
protein level with an elevated globulin fraction. Distal
RTA was confirmed based on the non-anion gap metabolic
acidosis and inappropriately high urinary pH.
The patient was given bicarbonate and her metabolic
acidosis improved. Systemic lupus erythematosous,
Sjögren’s syndrome, and rheumatoid arthritis were
excluded by negative anti-double stranded DNA antibo-
dies, antinuclear antibodies, and rheumatoid factor.
Cryoglobulins were not detected. Serum viscosity was 2.0
centipoises (normal: ≤1.5 centipoises). The patient was
negative for hepatitis B and C infection. Her liver, thyroid,
and parathyroid function were intact. A computed tomo-
graphy scan of the abdomen and pelvis demonstrated a
right sided kidney stone with moderate right sided
hydroureter. Serum and urine electrophoresis confirmed
a persistent discrete monoclonal component of IgM kappa
(40.7 g/L, normal: 0.2-1.4 g/L) in the gamma region.
During the hospital course, the patient developed pul-
monary edema, pleural effusions, and basilar infiltrates
suggestive of atelectasis. Left ventricular ejection fraction
was >60% on echocardiography. Her oxygenation
improved with intravenous diuretics and pulmonary
nebulizer treatment. The patient remained lethargic during
the first week of hospitalization and total parenteral
nutrition was initiated. A regular diet was resumed after
her mental status returned to baseline. Finally, her renal
function improved and her estimated glomerular filtration
rate returned to baseline. A renal biopsy was not obtained
because of her improved renal function and increased
bleeding risk with Coumadin therapy. After a hospital
course of 3 weeks, the hyperchloremic metabolic acidosis
resolved and she was successfully discharged to an
extended care facility. Follow-up tests 2 weeks later,
however, revealed a persistent hyperchloremic metabolic
acidosis suggestive of distal renal tubular acidosis.
Discussion
Distal (classic or type 1) RTA is a familiar or acquired
disorder of the distal nephron characterized by failure to
lower urinary pH resulting in a hyperchloremic metabolic
acidosis.Theunderlyingmechanismisnotwellunderstood
but proposed mechanisms include a defective proton
pump (secretory defect), an unfavorable electrical gradient
for H+ secretion (voltage defect) and back diffusion of H+
or bicarbonate (gradient or permeability defect) [8]. Distal
RTA can also lead to nephrolithiasis secondary to hyper-
calciuria,hyperphosphaturia,hypocitraturia,andlowurine
pH [9]. A urine pH >5.5 in the presence of non-anion gap
systemic metabolic acidosis is diagnostic for distal RTA.
Table 1. Laboratory results on hospital admission
Variable Reference range On admission
Glucose, mg/dL 70-105 87
Sodium, meq/L 136-145 147
Potassium, meq/L 3.5-5 4.6
Chloride, meq/L 98-106 120
Bicarbonate, meq/L 23-28 6
Anion gap 5-16 21
Blood urea nitrogen, mg/dL 8-20 61
Creatinine, mg/dL 0.7-1.3 2.4
Lactic acid, mmol/L 0.67-1.8 0.6
Calcium, mg/dL 9-10.5 9.5
Total protein, g/dL 6.0-7.8 10.9
Globulin, g/dL 2.5-3.5 7.3
Albumin, g/dL 3.5-5.5 3.6
Arterial blood gas
- pH 7.38-7.44 7.10
- pCO2, mmHg 35-45 31
- pO2, mmHg 80-100 88
Urine
- pH 5.0-8.0 6.0
- Protein, mg/dL <30 100
- Osmolality, mosm/kg 300-1000 360
- Sodium, meq/L - 37
- Potassium, meq/L - 18.1
- Creatinine, mg/dL - 79.4
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positive urine anion gap and a urine sodium >25 meq/L
[8]. In classic distal RTA, potassium levels are normal or
decreased. However, hyperkalemic or voltage-dependent
distalRTAalsoexistsandcanbeexplainedbyaninabilityto
maintain a negative intraluminal voltage which promotes
hydrogen and potassium secretion [8].
Our patient presented with severe lethargy and a mixed
anion-gap and non-anion gap metabolic acidosis which
were ascribed to uremia and distal RTA, respectively. The
patient’s age and clinical presentation made an inherited
form of distal RTA unlikely. Her past medical history of
hyperchloremic metabolic acidosis was suggestive of
chronic distal RTA. Screening for auto-immune disorders,
the major causes of distal RTA, was negative. The patient
had not been started on any new medications that could
have explained her presentation. We therefore concluded
that dysproteinemia secondary to Waldenström’s macro-
globulinemia may be a major contributing factor to her
long-standing chronic distal RTA and possibly to her acute
renal dysfunction.
The most common clinical manifestations of Walden-
ström’s macroglobulinemia include weakness, fatigue,
weight loss and chronic oozing of blood from the nose
and gums [10,11]. Hyperviscosity-related symptoms
include lethargy, which is often seen when serum viscosity
exceeds 4 centipoises [12]. Renal disease is infrequently
seen in Waldenström’s macroglobulinemia and mostly
presents as mild proteinuria and microscopic hematuria
[4]. Renal injury characteristically results from IgM kappa
or lambda granular intracapillary fibrillary deposits [3].
These deposits start as subendothelial deposits and may
lead to occlusion of the capillary lumen. Veltman and
colleagues demonstrated that renal failure in a patient
with Waldenström’s macroglobulinemia was caused by
IgM deposits along the glomerular basement membrane
and glomerular capillaries with mesangiocapillary glomer-
ulonephritis [5]. Martello and colleagues described a case
of renal disease caused by intramembranous IgM, IgG, and
C3 deposits [13]. In a minority of patients, macroglobu-
lins may precipitate in the cold (cryoglobulins) leading to
proteinuria and renal disease [2]. Literature on acute renal
dysfunction in Waldenström’s macroglobulinemia, as was
the case in our patient, is rare. Berkel and colleagues
reported a patient with acute renal failure as initial
manifestation of a malignant lymphoproliferative dis-
order with monoclonal light chain immunoglobulin
production [14]. Acute renal failure after contrast medium
administration in a patient with macroglobulinemia was
described by Matsumoto and colleagues [15].
To our knowledge, the association between distal RTA
and IgM hyperglobulinemia, such as Waldenström’s
macroglobulinemia,hasnotbeenreportedintheliterature.
Previous studies have demonstrated a rare association
between hypergammaglobulinemia and distal RTA [6,7].
The most common renal histopathological lesions in
hyperglobulinemic distal RTA are interstitial lymphocytic
infiltrates with tubular atrophy and fibrosis [16]. In
myeloma patients, monoclonal IgG production and
myeloma cast nephropathy are mainly responsible for
causing distal tubulo-interstitial lesions and distal RTA [3].
Cast nephropathy inWaldenström’smacroglobulinemia is
unlikelybecauseofthelowquantityofurinarymonoclonal
light chains. In Waldenström’s macroglobulinemia, inter-
stitial infiltration with malignant lymphoid cells
is common and present in around 60% of patients [4].
Unfortunately,norenalbiopsywasobtainedinourpatient.
It therefore remains unclear whether distal RTA in
Waldenström’s macroglobulinemia was caused by IgM
light-chain deposition or by lymphocytic infiltration.
Conclusions
Our case illustrates that patients with Waldenström’s
macroglobulinemia may present with distal RTA. Screen-
ing for distal RTA in these patients may be recommended,
especially since the investigations are simple and can be
done withblood and urinechemistry testing.Our casealso
suggests that Waldenström’s macroglobulinemia may be
a major contributing factor to the development of distal
RTA, and that these patients can develop acute renal
dysfunction. Early recognition and timely treatment of
these patients may prevent metabolic disturbances and
potentially life threatening complications.
Abbreviation
RTA, renal tubular acidosis.
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